Polycystic Ovary Syndrome Clinical Trial
Official title:
Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome
110 infertile women diagnosed as polycystic ovary syndrome (PCOS) at the age group of 20-35
distributed randomly :
- 55 women will receive letrozole 2.5mg twice daily orally from the 2nd day to the 6thday
of the cycle for three successive cycles.
- 55 women will receive clomiphene citrate 50 mg twice daily orally from the 2nd day to
the 6thday of the cycle for three successive cycles.
Patients will be subjected to:
Complete history taking:
1. Details about name, age
2. Menstrual history with determination of menarche
3. Amenorrhea or oligomenorrhea , Regularity of the cycle
4. History of endocrine disease.
5. History of previous operations.
- Physical examination:
- General examination:
With special concern to:
--Acne.
--Hirsutism .
--Weight.
--Height
--BMI was determined :
Wt. in kg ـــــــــــــــــــ =
) Height in m)2
- Abdominal examination :
- for scar of previous pelvic or abdominal operations .
- Pelvic examination :
- vaginal examination for enlarged cystic ovaries.
- ultrasound for diagnosis of pcos.
PARAMETERS:
(1) rate of ovulation (primary parameter). (2) serum progesterone level on day 21. (3)
number of mature follicles produced per cycle. (4) mean endometrial thickness. (6) chemical
pregnancy. (7) ongoing pregnancy
The aim of this study is to compare the efficacy of letrozole on ovulation induction to that
of clomiphene citrate in women suffering polycystic ovary syndrome.
Research question:
In women with PCOS , dose letrozole effective in ovulation induction as clomiphene citrate?
Researcher hypothesis:
In women with pcos , letrozole may be as effective as clomiphene citrate in ovulation
induction.
Patients and methods Site: this study will be recruited from women attending infertility
outpatient clinic at Ain Shams university maternity hospital.
Design: Randomized controlled trial.
Study population: 110 infertile women diagnosed as polycystic ovary syndrome (PCOS) at the
age group of 20-35 distributed randomly:
- 55 women will receive letrozole 2.5mg twice daily orally from the 2nd day to the 6thday
of the cycle for three successive cycles.
- 55 women will receive clomiphene citrate 50 mg twice daily orally from the 2nd day to
the 6thday of the cycle for three successive cycles.
Inclusion criteria:
1. Age between 20-35
2. Primary or secondary infertility
3. Patients diagnosed as PCOS according to Rotterdam criteria :
Menstrual irregularities:
- oligomenorrhea and/or anovulation.
- Oligomenorrhea (menses that occur at intervals greater than 35 days)
- Excess androgen activity. - Clinically: hirsutism .
- Biochemically: elevated serum androgen. polycystic ovaries (by gynecologic
ultrasound)
Exclusion criteria:
Any patients have any causes of infertility other than which mentioned in the inclusion
criteria as:
1. Hyperprolactinemia.
2. Male factor of infertility.
WHO Guidelines 2010 for Normal seminal fluid analysis :
- Volume> 1.5 ml
- ph 7.2 to 8.0
- Liquefaction time 20 to 30 min
- Sperms concentration >15 million/ml
- Total motility 40%(Progressive motility + non progressive motility)
- Progressive motility 32%
- Morphology > 4% normal forms
3. Thyroid dysfunction.
4. Diabetes Mellitus.
5. Known or suspicious tubal factor infertility ( by hysteroslapingograrhy (HSG) or
laparoscope.
6. Endometrioses or pelvic inflammatory diseases .
Patients will be subjected to:
Complete history taking:
1. Details a bout name, age
2. Menstrual history with determination of menarche
3. Amenorrhea or oligomenorrhea , Regularity of the cycle
4. History of endocrine disease.
5. History of previous operations.
Physical examination:
General examination:
With special concern to:
--Acne.
--Hirsutism .
- Weight.
- Height
- BMI was determined :
Wt. in kg ـــــــــــــــــــ =
) Height in m)2
- Abdominal examination:
for scar of previous pelvic or abdominal operations .
- Pelvic examination:
vaginal examination for enlarged cystic ovaries.
- ultrasound for diagnosis of pcos.
- The patients will randomly assigned to receive either letrozole (2.5 mg twice
daily ) or clomiphene citrate (50 mg twice daily ) from day 2 to day 6 of
menstrual cycle .
- Follicular monitoring will be done by transvaginal ultrasonography (TVS) on
alternate days from day 9 of menstrual cycle until a mature follicle detected.
Follicle considered mature when it attained 18 mm in size or more by averaging
inner two diameters of the follicle.
- A single injection of 10,000 IU human chorionic gonadotrophin (hCG) will be given,
if at least one follicle attained 18 mm. TVS will be done after 48 h of hCG
injection to determine follicle rupture. If the follicle found unruptured, TVS
repeated after 72 h of the hCG injection to detect whether follicle has ruptured
or not. Ovulation ascertained by observing rupture of the follicle by
ultrasonogram (USG).
- Endometrial thickness of 8 mm considered a satisfactory response of the
endometrium.
- on day 21 serum progesterone level will measured. A progesterone level of 10 ng/ml
considered as ovulatory.
PARAMETERS
Primary outcome measure :
(1) Rate of ovulation assessed by number of mature follicles produced per cycle .
Secondary outcome measures :
(2) Serum progesterone level on day 21 ( assessed up to 24 weeks). (3) Mean endometrial
thickness ( assessed up to 24 weeks). (4) Chemical pregnancy ( assessed up to 24 weeks). (5)
Ongoing pregnancy ( assessed up to 24 weeks).
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03142633 -
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
|
||
Completed |
NCT06158932 -
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Completed |
NCT04932070 -
Berberine and Polycystic Ovary Syndrome
|
N/A | |
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT03480022 -
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
|
Phase 3 | |
Active, not recruiting |
NCT03043924 -
Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT05246306 -
Aerobic Capacity and Physical Fitness Level of Adolescents With PCOS
|
||
Completed |
NCT05981742 -
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
|
Phase 2 | |
Completed |
NCT05702957 -
Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT05029492 -
Effect of Visceral Manipulation on PCOS
|
N/A | |
Completed |
NCT02924025 -
Motivational Interviewing as an Intervention for PCOS
|
N/A | |
Not yet recruiting |
NCT02255578 -
Endobarrier Treatment in Women With PCOS
|
Phase 3 | |
Withdrawn |
NCT01638988 -
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
|
Phase 3 | |
Completed |
NCT02098668 -
Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
|
N/A | |
Not yet recruiting |
NCT00883259 -
Metformin and Gestational Diabetes in High-risk Patients: a RCTs
|
Phase 4 | |
Completed |
NCT01462864 -
Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome
|
N/A | |
Recruiting |
NCT01431352 -
Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT00989781 -
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
|
N/A |